Medtronic Hugo Robotic IDE Trial
Robotic-assisted surgery reduces surgical trauma, minimises complications and shortens hospitalisation compared to open techniques.
The study aims to validate an integrated surgical ecosystem that combines robotics, imaging, instrumentation and workflow optimisation.
Medtronic has launched the Embrace Gynecology US investigational device exemption (IDE) study to evaluate the safety and effectiveness of its Hugo robotic-assisted surgery (RAS) system in gynaecological procedures.
The Hugo system is designed to deliver a unified platform integrating robotic control, procedural planning and device interoperability.
Unlike conventional gynaecological surgery, which can be limited by variability in technique and procedural complexity
Author summary: Medtronic launches Hugo robotic IDE trial for gynaecology surgery.